Bausch + Lomb Corporation
NYSE:BLCOMedical - Instruments & Supplies
+$0.04 today
- Market cap
- $7.49B
- Beta
- 0.57
- P/E (TTM)
- -24.2
- EPS (TTM)
- -$0.62
Volume 0.51M
Average 0.46M
BLCO Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Bausch + Lomb CorporationNYSE: BLCO
Other Income / Expenses · Q2 FY2026 · quarter ended Jun 2026
Other income / expenses remains negative
Q2 FY2026 other income / expenses was -$94M, compared with -$158M a year earlier. Trailing-twelve-month other income / expenses was -$445M.
Context
- Other income / expenses amounted to 9.9% of revenue in FY2025, up 1.6 pp from a year earlier.
- Other income / expenses grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other income / expenses holds near -$94M or moves back toward the trailing-twelve-month quarterly average of -$111.25M.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- (505M) USD
- Year-over-year change
- -27.5%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (505M) | -27.5% |
| FY2024 | 2024-12-31 | (396M) | -33.8% |
| FY2023 | 2023-12-31 | (296M) | -120.9% |
| FY2022 | 2022-12-31 | (134M) | -1118.2% |
| FY2021 | 2021-12-31 | (11M) | — |
Other Income / Expenses vs competitors
How BLCO compares with its peers on the latest reported figures
- BLCO's LTM Jun 2026 other income / expenses of -$445M is the 9th highest of the 10 companies compared; the peer median is -$34.29M.
- Its year-over-year change of +6.3% is the 4th highest of 10, against a peer median of -91.3%.
- Other income / expenses amounts to 8.4% of revenue for BLCO, versus a peer median of 11.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $101.03M | -37.5% | +161.6% | — | |
| LTM Sep 2026 | $76.21M | +1284.2% | — | 302.7% | |
| LTM Sep 2026 | -$5.66M | +76.2% | — | 0.4% | |
| LTM Sep 2026 | -$16.74M | +64.2% | — | 3.7% | |
| LTM Jun 2026 | -$34.29M | -91.3% | — | 0.2% | |
| LTM Sep 2026 | -$43.31M | -188.2% | — | 4.8% | |
| LTM Jun 2026 | -$112.34M | -2575.6% | — | 18.3% | |
| LTM Jun 2026 | -$183.33M | -250.6% | — | 18.2% | |
| LTM Jun 2026 | -$445M | +6.3% | — | 8.4% | |
| LTM Jun 2026 | -$496.77M | -591.6% | — | 19.1% | |
| Peer median (excluding BLCO) | -$34.29M | -91.3% | +161.6% | 11.5% | |
Competitors are the stored peer set for BLCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.77B | 3.77B | 4.15B | 4.79B | 5.1B |
| Cost of Revenue | 1.47B | 1.52B | 1.64B | 1.87B | 2.31B |
| Gross Profit | 2.3B | 2.25B | 2.5B | 2.92B | 2.79B |
| Gross Margin | 61.0% | 59.7% | 60.4% | 60.9% | 54.8% |
| Research & Development | 271M | 307M | 324M | 343M | 371M |
| Selling, General & Admin | 1.39B | 1.48B | 1.74B | 2.08B | 2.23B |
| Operating Expenses | 1.97B | 2.04B | 2.37B | 2.76B | 2.61B |
| Depreciation & Amortization | 415M | 379M | 382M | 436M | 421M |
| EBITDA | 733M | 598M | 499M | 601M | 535M |
| EBITDA Margin | 19.5% | 15.9% | 12.0% | 12.5% | 10.5% |
| Operating Income | 329M | 207M | 130M | 162M | 188M |
| Operating Margin | 8.7% | 5.5% | 3.1% | 3.4% | 3.7% |
| Interest Income | 0 | 6M | 15M | 15M | 12M |
| Interest Expense | 0 | 146M | 283M | 399M | 431M |
| Other Income / Expenses | (11M) | (134M) | (296M) | (396M) | (505M) |
| Income Before Tax | 318M | 73M | (166M) | (234M) | (317M) |
| Pre-Tax Margin | 8.4% | 1.9% | -4.0% | -4.9% | -6.2% |
| Income Tax Expense | 125M | 58M | 82M | 71M | 35M |
| Net Income | 182M | 6M | (260M) | (317M) | (360M) |
| Net Margin | 4.8% | 0.2% | -6.3% | -6.6% | -7.1% |
| EPS (Basic) | 0.52 | 0.04 | (0.74) | (0.90) | (1.02) |
| EPS (Diluted) | 0.52 | 0.04 | (0.74) | (0.90) | (1.02) |
| Weighted Avg Shares | 350M | 350M | 350.5M | 351.8M | 353.8M |
| Weighted Avg Shares (Diluted) | 350M | 350M | 350.5M | 351.8M | 353.8M |
Bausch + Lomb Corporation
NYSE:BLCO
Intrinsic Alpha fair value
Locked
Current Price
$20.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.